Birth defect risk with valproate
News Previous     Next

Birth defect risk with valproate

A drug for treating epilepsy and bipolar disorder should no longer be prescribed for women or girls of childbearing age unless they are on the pregnancy prevention programme (PPP).

Nursing Children and Young People. 30, 3,7-7. doi: 10.7748/ncyp.30.3.7.s4

You need a subscription to read the full article